The flt3 Ligand Promotes the Survival of Primitive Hemopoietic Progenitor Cells with Myeloid as Well as B Lymphoid Potential: Suppression of Apoptosis and Counteraction by TNF-α and TGF-β

Journal of Immunology

Volumn 157, Issue 7, 1996, Pages 2953-2960

  Veiby, Ole P ^a   Jacobsen, Frede W ^b   Cui, Li ^a   Lyman, Stewart D ^c   Jacobsen, Sten E W ^a  

^a Cancer Prevention Institute Dayton   (United States)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; FLT3 LIGAND PROTEIN; FLT3 PROTEIN, HUMAN; FLT3 PROTEIN, MOUSE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 7; MEMBRANE PROTEIN; ONCOPROTEIN; PROTEIN TYROSINE KINASE; RECOMBINANT PROTEIN; STEM CELL FACTOR;

ANIMAL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; C57BL MOUSE; CELL DIVISION; CELL LINEAGE; CELL SURVIVAL; CLONOGENIC ASSAY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MOUSE; PHYSIOLOGY; RADIATION CHIMERA;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CELL DIVISION; CELL LINEAGE; CELL SURVIVAL; COLONY-FORMING UNITS ASSAY; DRUG SYNERGISM; FMS-LIKE TYROSINE KINASE 3; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC CELL GROWTH FACTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-7; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS; RADIATION CHIMERA; RECEPTOR PROTEIN-TYROSINE KINASES; RECOMBINANT PROTEINS; STEM CELL FACTOR;

EID: 0030267526     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Metcalf, D. 1989. The molecular control of cell division, differentiation, commitment and maturation in hematopoietic cells. Nature 339:27.
2. Whetton, A. D., and T. M. Dexter. 1989. Myeloid haemopoietic growth factors. Biochim. Biopyhs. Acta 989:111.
3. Moore, M. A. S. 1991. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 78:1.
4. Metcalf, D. 1993. Hematopoietic regulators: redundancy or subtlety? Blood 82: 3515.
5. Leary, A. G., H. Q. Zeng, S. C. Clark, and M. Ogawa. 1992. Growth factor requirements for survival in GO and entry into the cell cycle of primitive human hemopoietic progenitors. Proc. Natl. Acad. Sci. USA 89:4013.
6. Katayama, N., S. C. Clark, and M. Ogawa. 1993. Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors. Blood 81:610.
7. Li, C. L., and G. R. Johnson. 1994. Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells. Blood 84:408.
8. Brandt, J. E., K. Bhalla, and R. Hoffman. 1994. Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells. Blood 83:1507.
9. Jacobsen, F. W., T. Stokke, and S. E. W. Jacobsen. 1995. Transforming growth factor-β potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells. Blood 86:2957.
10. Jacobsen, F. W., O. P. Veiby, T. Stokke, and S. E. W. Jacobsen. 1996. Tumor necrosis factor-α bidirectionally modulates the viability of primitive murine hematopoietic progenitor cells in vitro. J. Immunol. 157:1193.
11. Zsebo, K. M., J. Wypych, I. K. McNiece, H. S. Lu, K. A. Smith, S. B. Karkare, R. K. Sachdev, V. N. Yuschenkoff, N. C. Birkett, L. R. Williams, V. N. Satyagai, W. Tung, R. A. Bosselman, E. A. Mendiaz, and K. E. Langley. 1990. Identification, purification and biological characterization of hematopoietic stem cell factor from Buffalo rat liver-conditioned medium. Cell 63:195.
12. Williams, D. E., J. Eisenman, A. Baird, C. Rauch, K. van Ness, C. J. March, L. S. Park, U. Martin, D. Mochizuki, H. S. Boswell, G. Burgess, and S. D. Lyman. 1990. Identification of a ligand for the c-kit proto-oncogene. Cell 63:167.
13. Huang, E., K. Nocka, D. R. Beier, T. Y. Chu, J. Buck, H. W. Lahm, D. Wellner, P. Leder, and P. Besmer. 1990. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63:225.
14. McNiece, I. K., K. E. Langley, and K. M. Zsebo. 1991. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and Epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp. Hematol. 19:226.
15. - murine hematopoietic progenitors. Exp. Hematol. 19:994.
16. Metcalf, D., and N. A. Nicola. 1991. Direct proliferative actions of stem cell factor on murine bone marrow cells in vitro: effects of combination with colony-stimulating factors. Proc. Natl. Acad. Sci. USA 88:6239.
17. de Vries, P., V. A. Brasel, J. R. Eisenmann, A. R. Alpert, and D. E. Williams. 1991. The effects of recombinant mast cell growth factor on purified murine hematopoietic stem cells. J. Exp. Med. 173:1205.
18. Tsuji, K., S. D. Lyman, T. Sudo, S. C. Clark, and M. Ogawa. 1992. Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture. Blood 79:2855.
19. Williams, N., I. Bertoncello, H. Kavnoudias, K. Zsebo, and I. McNiece. 1992. Recombinant rat stem cell factor stimulates the amplification and differentiation of fractionated mouse stem cell populations. Blood 79:58.
20. Jacobsen, S. E. W., O. P. Veiby, and E. B. Smeland. 1993. Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells. J. Exp. Med. 178:413.
21. Briddell, R. A., E. Bruno, R. J. Cooper, J. E. Brandt, and R. Hoffman. 1991. Effect of c-kit ligand on in vitro human megakaryocytopoiesis. Blood 78:2854.
22. Keller, J. R., M. Ortiz, and F. W. Ruscetti. 1995. Steel factor (c-kit ligand) promotes the survival of hematopoietic stem/progenitor cells in the absence of cell division. Blood 86:1757.
23. Chabot, B., D. A. Stephenson, V. M. Chapman, P. Besmer, and A. Bernstein. 1988. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335:88.
24. Geissler, E. N., M. A. Ryan, and D. E. Housman. 1988. The dominant white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 55:185.
25. Sherr, C. J., C. W. Rettenmeier, R. Sacca, M. F. Roussel, A. T. Look, and E. R. Stanley. 1985. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665.
26. Rosnet, O., S. Marchetto, O. deLapeyriere, and D. Birnbaum. 1991. Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF-1R family. Oncogene 6:1641.
27. Matthews, W., C. T. Jordan, G. W. Wiegand, D. Pardoll, and I. R. Lemischka. 1991. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65:1143.
28. Lyman, S. D., L. James, T. V. Bos, P. de Vries, K. Brasel, B. Gliniak, L. T. Hollingsworth, S. Picha, H. J. McKenna, R. R. Splett, F. A. Fletcher, E. Maraskovsky, T. Farrah, D. Foxworthe, D. E. Williams, and M. P. Beckmann. 1993. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 75:1157.
29. Hannum, C., J. Culpepper, D. Campbell, T. McClanahan, S. Zurawski, J. F. Bazan, R. Kastelein, S. Hudak, J. Wagner, J. Mattson, J. Luh, G. Duda, N. Martina, D. Peterson, S. Menon, A. Shanafelt, M. Muench, G. Keiner, R. Namikawa, D. Rennick, M. Roncarolo, A. Zlotnik, O. Rosnet, P. Dubreuil, D. Birnbaum, and F. Lee. 1994. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of heamatopoietic stem cells and is encoded by variant RNAs. Nature 368:643.
30. Lyman, S. D., L. James, L. Johnson, K. Brasel, P. de Vries, S. S. Escobar, H. Downey, R. R. Splett, M. P. Beckmann, and H. J. McKenna. 1994. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 83:2795.
31. Jacobsen, S. E. W., C. Okkenhaug, J. Myklebust, O. P. Veiby, and S. D. Lyman. 1995. The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. J. Exp. Med. 181:1357.
32. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc. Natl. Acad. Sci. USA 91:459.
33. - cells and maintains progenitor cells in vitro. Blood 87:3563.
34. Muench, M. O., M. G. Roncarolo, S. Menon, Y. Xu, R. Kastelein, S. Zurawski, C. H. Hannum, J. Culpepper, F. Lee, and R. Namikawa. 1995. FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 85:963.
35. Spangrude, G. J., S. Heimfeld, and I. L. Weissman. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241:58.
36. Spangrude, G. J., and R. Scollay. 1990. A simplified method for enrichment of mouse hematopoietic stem cells. Exp. Hematol. 18:920.
37. Veiby, O. P., S. D. Lyman, and S. E. W. Jacobsen. 1996. Combined signaling through IL-7 receptors and flt3 but not c-kit potently and selectively promotes B cell commitment and differentiation from uncommitted murine bone marrow progenitor cells. Blood. 88:1256.
38. Spooncer, E., J. Eliason, and T. M. Dexter. 1993. Long-term mouse bone marrow cultures. In Haemopoiesis. N. G. Testa and G. Molineux, eds. IRL Press, Oxford, p. 55.
39. Gorczyca, W., J. Gong, and Z. Darzynkiewicz. 1993. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53:1945.
40. Johnson, G. D., and G. M. C. Nogueria Araujo. 1981. A simple method of reducing the fading of immunofluorescence during microscopy. J. Immunol. Methods 43:349.
41. Galli, S. J., K. Zsebo, and E. N. Geissler. 1994. The kit ligand, stem cell factor. Adv. Immunol. 55:1.
42. Langley, K. E., L. G. Bennett, J. Wypych, S. A. Yancik, X. Liu, K. R. Westcott, D. G. Chang, K. A. Smith, and K. M. Zsebo. 1993. Soluble stem cell factor in human serum. Blood 81:656.
43. Li, C. L., and G. R. Johnson. 1995. Murine hematopoietic stem and progenitor cells. I. Enrichment and biologic characterization. Blood 85:1472.
44. Williams, G. T., C. A. Smith, E. Spooncer, T. M. Dexter, and D. R. Taylor. 1990. Haematopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76.
45. Koury, M. J., and M. C. Bondurant. 1990. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248: 378.
46. Keller, J. R., C. Mantel, G. K. Sing, L. R. Ellingsworth, S. K. Ruscetti, and F. W. Ruscetti. 1988. Transforming growth factor-beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3 dependent myeloid leukemic cells. J. Exp. Med. 168:737.
47. Keller, J. R., I. K. McNiece, K. T. Sill, L. R. Ellingsworth, P. J. Quesenberry, G. K. Sing, and F. W. Ruscetti. 1990. Transforming growth factor β directly regulates primitive murine hematopoietic cell proliferation. Blood 75:596.
48. Keller, J. R., S. E. W. Jacobsen, K. T. Sill, L. R. Ellingsworth, and F. W. Ruscetti. 1991. Stimulation of granulopoiesis by transforming growth factor β: synergy with granulocyte/macrophage-colony-stimulating factor. Proc. Natl. Acad. Sci. USA 88:7190.
49. Degliantoni, G., M. Murphy, M. Kobayashi, M. K. Francis, B. Perussia, and G. Trinchieri. 1985. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor: relationship with tumor necrosis factor and synergy with immune interferon. J. Exp. Med. 162:1512.
50. Broxmeyer, H. E., D. E. Williams, L. Lu, S. Cooper, S. L. Anderson, G. S. Beyer, R. Hoffman, and B. Y. Rubin. 1986. The suppressive influences of human tumor necrosis factor on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. J. Immunol. 136:4487.
51. Murphy, M., B. Perussia, and G. Trinchieri. 1988. Effects of recombinant tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells. Blood 69:467.
52. Jacobsen, S. E. W., F. W. Ruscetti, C. M. Dubois, and J. R. Keller. 1992. Tumor necrosis factor alpha directly and indirectly regulates hematopoietic progenitor cell proliferation: role of colony-stimulating factor receptor modulation. J. Exp. Med. 175:1759.
53. Jacobsen, F. W., M. Rothe, L. S. Rusten, D. V. Goeddel, E. B. Smeland, O. P. Veiby, L. Slørdal, and S. E. W. Jacobsen. 1994. Role of the 75-kDa tumor necrosis factor receptor: inhibition of early hematopoiesis. Proc. Natl. Acad. Sci. USA 91:10695.
54. + hematopoietic progenitor cells. Blood 75:2292.
55. Caux, C., C. Favre, S. Saeland, V. Duvert, I. Durand, P. Mannoni, and J. Banchereau. 1991. Potentiation of early hematopoiesis by tumor necrosis factor-α is followed by inhibition of granulopoietic differentiation and proliferation. Blood 78:635.
56. Rusten, L. S., F. W. Jacobsen, W. Lesslauer, H. Loetscher, E. B. Smeland, and S. E. W. Jacobsen. 1994. Bifunctional effects of tumor necrosis factor α (TNF-α) on the growth of mature and primitive human hematopoietic progenitor cells: involvement of p55 and p75 TNF receptors. Blood 83:3152.
57. Jacobsen, S. E. W., O. P. Veiby, J. Myklebust, C. Okkenhaug, and S. D. Lyman. 1996. Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-β and tumor necrosis factor-α. Blood. 87:5016.
58. Rasko, J. E. J., D. Metcalf, M. T. Rossner, C. G. Begley, and N. A. Nicola. 1995. The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation. Leukemia 9:2058.
59. Hudak, S., B. Hunte, J. Culpepper, S. Menon, C. Hannum, L. Thompson-Snipes, and R. Rennick. 1995. FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units. Blood 85:2747.
60. Broxmeyer, H. E., L. Lu, S. Cooper, L. Ruggieri, Z. Li, and S. D. Lyman. 1996. Flt3 ligand stimulates/costimulates the growth of myeloid stem/progenitor cells. Exp. Hematol. 23:1121.
61. Mackarehtschian, K., J. D. Hardin, K. Moore, S. Boast, S. P. Goff, and I. R. Lemischka. 1995. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147.
62. Namikawa, R., M. O. Muench, J. E. de Vries, and M. Roncarolo. 1996. The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro. Blood 87:1881.
63. Ziegler, F. C., B. D. Bennett, C. T. Jordan, S. D. Spencer, S. Baumhueter, K. J. Carroll, J. Hooley, K. Bauer, and W. Matthews. 1994. Cellular and molecular characterization of the FLK-2/FLT-3 receptor tyrosine kinase in hematopoietic cells. Blood 84:2422.
64. Okada, S., H. Nakauchi, K. Nagayoshi, S. Nishikawa, Y. Miura, and T. Suda. 1992. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood 80:3044.
65. Okada, S., H. Nakauchi, K. Nagayoshi, S. Nishikawa, S. Nishikawa, Y. Miura, and T. Suda. 1991. Enrichment and characterisation of murine hematopoietic stem cells that express c-kit molecule. Blood 78:1706.
66. + B precursor cells by two distinct signals derived from IL-7 receptor and c-kit in a fully defined medium. J. Exp. Med. 182:315.
67. Magli, M. C., N. N. Iscove, and N. Odartchenko. 1982. Transient nature of early haematopoietic spleen colonies. Nature 295:527.
68. Lemieux, M. E., V. I. Rebel, P. M. Lansdorp, and C. J. Eaves. 1995. Characterization and purification of a primitive hematopoietic cell type in adult mouse marrow capable of lymphomyeloid differentiation in long-term marrow "switch" cultures. Blood 86:1339.
69. Lemischka, I. R., D. H. Raulet, and R. C. Mulligan. 1986. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 45:917.
70. Sachs, L., and J. Lotem. 1993. Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 82:15.
71. Lotem, J., and L. Sachs. 1992. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor β1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 80:1750.
72. Spangrude, G. J., L. Smith, N. Uchida, K. Ikuta, S. Heimfeld, J. Friedman, and I. L. Weissman. 1991. Mouse hematopoietic stem cells. Blood 78:1395.